ArticleAmerican journal of cancer research2024

A novel immunogenic cell death-related gene risk signature can identify biomarkers of gliomas and predict the immunotherapeutic response.

Xuewu Tang et al.PubMed ↗Full text ↗

No numbers read from the abstract.